Stock UniverseDerived research view · source repositories remain read-only

Natera, Inc. (NTRA)

Life Science Tools / Diagnostics / MedTech · Healthcare / Diagnostics & Research
Score Band
High
Selection Score
42.97
Global Rank
182
Market Cap
29.06B
Latest Close
215.31
RS Composite
-5.84% · G#1811

Price Movement

3Y daily adjusted close
Loading price data...
Adjusted close SMA60D
1M
0.10%
3M
8.67%
6M
-9.61%
1Y
28.76%
3Y
357.04%
5Y
128.71%
10Y
1461.35%

Volume

Loading volume data...
Volume Volume MA20D

Latest volume: 848.90K · 30-day average: 1.61M · Max drawdown over stored range: -77.74%

Research Snapshot

Relative Strength vs SPX

RS Composite-5.84%
20D RS-2.69%
60D RS0.54%
120D RS-13.81%
Global RS Rank1811 · 46.02% percentile
Qualified+ RS Rank663 · 47.30% percentile
Group ScopeQualified+
Primary RS Rank58 · 59.15% percentile
Snapshot Date2026-06-05

RS uses adjusted close where available. Global RS Rank is recalculated from the current non-low pool. Group RS Rank is recalculated inside the company’s own actionable band group.

Research Links

StockAnalysis
Yahoo Finance
Perplexity Finance
Finviz
Seeking Alpha
WhaleWisdom
FinanceCharts
SEC EDGAR Search
SEC Company Search

Official company website and investor-relations URLs are not inferred unless a reliable dynamic source is added.

Classification

Primary Rank15 / 246
Primary Percentile94.31
Score Notesmarket-cap support, industry-tailwind

Gemini Deep Research

Loading Gemini reports...

Manual Estimates

Loading manual estimates...

Forward Valuation

Loading forward valuation...

SEC TTM Fundamentals

PeriodFiledRevenueGross ProfitOperating IncomeNet IncomeEPS DilutedOperating Cash FlowCapital ExpenditureFree Cash FlowShares DilutedGross MarginOperating MarginNet MarginOCF MarginFCF MarginCash + ST Inv.Total Debt
TTM through 2026-03-312026-05-082.50B1.63B-324.25M-226.31M-1.64337.50M176.04M161.46M138M65.07%-12.97%-9.05%13.49%6.46%1.09B80.31M

SEC TTM. Read-only SEC TTM snapshot. Shares Diluted is the rolling average across the four-quarter window.

TTM Valuation

PeriodEPS DilutedP/ERevenue / ShareP/SFCF / ShareP/FCF MultipleOCF / ShareP/CF Multiple
TTM through 2026-03-31$-1.64-131.6x$18.0811.9x$1.17184.5x$2.4488.3x

Shares Diluted: 138M. SEC TTM. Read-only SEC TTM snapshot. Shares Diluted is the rolling average across the four-quarter window.

Financial Statement Metrics

MetricFY 2020FY 2021FY 2022FY 2023FY 2024FY 2025
Revenue391.005625.486820.2221082.5711696.9112306.113
Revenue Growth (YoY)29.331%59.969%31.134%31.985%56.748%35.901%
Gross Profit187.385307.068363.966492.741023.1581493.18
Operating Income-216.277-468.174-541.04-446.245-222.294-309.911
Free Cash Flow-202.116-384.824-479.198-286.15469.241109.113
Free Cash Flow Per Share-2.495-4.249-4.87-2.4880.5550.798
EPS (Diluted) GAAP-2.835948-5.208993-5.56661-3.780976-1.526852-1.522516
EPS Growth
EPS Non-GAAP
Gross Margin47.924%49.093%44.374%45.516%60.295%64.749%
Operating Margin-55.313%-74.85%-65.963%-41.221%-13.1%-13.439%
Profit Margin-58.757%-75.416%-66.787%-40.164%-11.222%-9.026%
Free Cash Flow Margin-51.691%-61.524%-58.423%-26.433%4.08%4.731%
Shares Outstanding (Diluted)81.01190.55898.408114.997124.718136.721
Shares Change (YoY)16.47%11.785%8.668%16.857%8.453%9.624%

SEC Quarterly Fundamentals

Revenue + Operating Margin
Loading SEC quarterly chart...
Revenue Operating Margin
Quarter Filed Revenue Gross Margin Operating Income Op Margin Net Income Net Margin EPS Diluted Shares Diluted Cash + ST Inv. Total Debt Confidence
2026 Q12026-05-08696.64M64.71%-93.52M-13.42%-85.09M-12.21%-0.60141.50M1.09B80.31Mprocessed
2025 Q42026-02-27665.50M66.93%-22.79M-3.42%47.26M7.10%0.34138.34M1.10B80.32Mprocessed
2025 Q32025-11-07592.18M64.91%-97.58M-16.48%-87.54M-14.78%-0.64137.19M1.04B80.34Mprocessed
2025 Q22025-08-08546.60M63.41%-110.37M-20.19%-100.94M-18.47%-0.74136.39M1.02B80.34Mprocessed
2025 Q12025-05-09501.83M63.12%-79.18M-15.78%-66.94M-13.34%-0.50134.75M991.60M80.34Mprocessed
2024 Q42025-02-28476.06Mn/a-64.74M-13.60%-53.77M-11.29%-0.41131.41M968.28M363.31Mprocessed
2024 Q32024-11-12439.76Mn/a-39.34M-8.95%-31.59M-7.18%-0.26123.78M922.33M367.02Mprocessed
2024 Q22024-08-09413.35Mn/a-43.90M-10.62%-37.46M-9.06%-0.30122.85M887.10M363.99Mprocessed
2024 Q12024-05-10367.74Mn/a-74.31M-20.21%-67.60M-18.38%-0.56120.81M882.94M363.67Mprocessed
2023 Q42024-02-29311.11Mn/a-84.54M-27.17%-78.03M-25.08%-0.65119.31M878.98M363.35Mprocessed
2023 Q32023-11-09268.31Mn/a-110.98M-41.36%-109.03M-40.64%-0.95115.17M936.56M363.05Mprocessed
2023 Q22023-08-04261.40Mn/a-112.43M-43.01%-110.80M-42.39%-0.97113.69M735.94M362.71Mprocessed
2023 Q12023-05-10241.76Mn/a-138.30M-57.21%-136.94M-56.64%-1.23111.77M812.01M362.37Mprocessed
2022 Q42023-03-01217.25Mn/a-141.77M-65.26%-142.57M-65.63%-1.37104.41M898.31M362.00Mprocessed
2022 Q32022-11-09210.64Mn/a-119.05M-56.52%-121.48M-57.67%-1.2597.05M521.15M331.48Mprocessed
2022 Q22022-08-05198.20Mn/a-143.09M-72.19%-145.15M-73.23%-1.5096.58M638.65M331.11Mprocessed
2022 Q12022-05-06194.13Mn/a-137.13M-70.64%-138.59M-71.39%-1.4595.58M751.96M330.76Mprocessed
2021 Q42022-02-25173.03Mn/a-139.67M-80.72%-140.56M-81.24%n/an/a914.28M330.45Mprocessed
2021 Q32021-11-05158.12Mn/a-150.20M-94.99%-151.27M-95.67%n/an/a1.02B330.13Mprocessed
2021 Q22021-08-06142.03Mn/a-115.29M-81.18%-116.03M-81.69%n/an/a580.24M329.83Mprocessed

SEC processed quarterly CSV. Compact derived quarterly view from SEC processed CSV. Source files remain read-only in the SEC repository. EPS is as filed and may not be split-adjusted across older periods. StockAnalysis Financial Statement Metrics remain unchanged above.